Abbott announced that it has received 510(k) clearance from the FDA to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation’s most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia.
Read MoreUS Department of Health and Human Services Secretary Kathleen Sebelius today announced $250 million in new Affordable Care Act investments to support prevention activities and develop the nations public health infrastructure.
Read MoreIn the June Anesthesiology researchers take aim at identifying genetic risk factors for sepsis a leading cause of death for critically ill patients.
Read More
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MoreThe National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for a two-year study, which will focus on development of novel, recombinant-based diagnostic tests for the Ebola and Marburg viruses.
Read More